Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Identification of Preservatives in Multi-Dose Vials – V 2.0

Posted on By

Analytical Method Development: SOP for Identification of Preservatives in Multi-Dose Vials – V 2.0

Standard Operating Procedure for Identification of Preservatives in Multi-Dose Vials in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/273/2025
Supersedes SOP/AMD/273/2022
Page No. Page 1 of 11
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define the validated procedure for identification and quantification of antimicrobial preservatives in multi-dose injectable pharmaceutical formulations using chromatographic and spectroscopic techniques, ensuring patient safety and regulatory compliance.

2.

Scope

This SOP applies to the Analytical Method Development and Quality Control departments for the evaluation of preservatives such as benzyl alcohol, phenol, methylparaben, and propylparaben in injectable dosage forms.

3. Responsibilities

  • Analytical Chemist: Develops, executes, and validates the test method for preservative detection.
  • QC Analyst: Conducts sample testing and documents observations.
  • QA Executive: Ensures protocol adherence, reviews data, and approves the report.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring validated, accurate, and sensitive methods are in place for detecting preservatives in sterile multi-dose formulations.

5. Procedure

5.1 Target Analytes

  • Benzyl alcohol
  • Phenol
  • Methylparaben
  • Propylparaben

5.2 Sample Preparation

  1. Withdraw 1 mL of the injectable solution using aseptic technique.
  2. Transfer into a 10 mL volumetric flask and dilute with mobile phase (e.g., water:acetonitrile 60:40 v/v).
  3. Filter the solution through a 0.45 µm membrane filter.

5.3 Standard Preparation

  1. Prepare individual and mixed standard solutions of all target preservatives in mobile phase at known concentrations (e.g., 100 µg/mL).
  2. Store under refrigeration (2–8°C) and protect from light.

5.4 Chromatographic Conditions (HPLC)

  • Column: C18, 250 mm × 4.6 mm, 5 µm
  • Mobile Phase: Water:Acetonitrile (60:40), adjusted to pH 3.0 with phosphoric acid
  • Flow Rate: 1.0 mL/min
  • Detection Wavelength: 254 nm
  • Injection Volume: 20 µL

5.5 Identification and Quantification

  1. Inject standard and sample solutions into HPLC.
  2. Compare retention times and UV spectra for identification.
  3. Quantify using external standard calibration curve method.

5.6 Acceptance Criteria

  • Preservative must be present within 90%–110% of declared content.
  • Retention time difference between standard and sample ≤ ±2%.
  • No interfering peaks at retention time of target preservatives.

5.7 Method Validation Parameters

  1. Specificity: Should clearly resolve preservatives from each other and from excipients.
  2. Linearity: r² ≥ 0.999 in the range of 50–150 µg/mL.
  3. Accuracy: Recovery between 98%–102% at three concentration levels.
  4. Precision: RSD ≤ 2% for repeatability and intermediate precision.
  5. LOD/LOQ: Determine using signal-to-noise ratio method.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • RSD: Relative Standard Deviation
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • QA: Quality Assurance

7. Documents

  1. Preservative Identification Log – Annexure-1
  2. Chromatograms Set – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • USP <51>: Antimicrobial Effectiveness Testing
  • ICH Q2(R1): Validation of Analytical Procedures
  • FDA Guidance on Preservative Content in Injectable Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Vinita Iyer Narendra Joshi Sunita Reddy
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Preservative Identification Log

Sample ID Preservative Retention Time (min) Declared (%) Found (%) Status
MDV-273-01 Benzyl Alcohol 4.82 0.9% 0.91% Pass

Annexure-2: Chromatograms Set

Overlay chromatograms of standard and sample injections showing matched retention times and clean baseline separation for benzyl alcohol and methylparaben.

Annexure-3: Validation Summary Report

The HPLC method for identifying and quantifying preservatives in multi-dose vials was validated across five formulations. Accuracy, precision, and linearity criteria were successfully met. The method is suitable for routine and regulatory testing.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Added new preservatives to scope, updated annexures Annual Review Sunita Reddy
10/04/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Management of Stability-Indicating Method Validation - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Peer Review Programs to Enhance SOP Compliance
Next Post: Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version